AQP4 and myeloid sarcoma: A major advancement that helped to distinguish NMOSD from MS was the discovery that 75% of patients with NMOSD have detectable serum IgG auto-antibodies against the aquaporin-4 water channel (AQP4), an intergral water channel protein in astrocytes (138).